(HealthDay News) — The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive meningococcal disease (IMD), ...

Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).

The postponed ACIP meeting comes barely a week after Robert F. Kennedy, Jr. was confirmed as Secretary of Health and Human ...

At two Senate confirmation hearings, Kennedy played down his well-publicised questioning of the safety of childhood vaccines – including debunked claims that they can cause autism – but refused to ...

A Centers for Disease Control and Prevention vaccine advisory committee meeting scheduled for next week — the first since ...

Less than a week after newly confirmed Department of Health and Human Services (HHS) secretary Robert F. Kennedy Jr. | Less than a week after newly confirmed HHS secretary Robert F. Kennedy Jr.

A panel of experts advising the U.S. Centers for Disease Control and Prevention on vaccines will not convene for its February ...

A panel of experts advising the U.S. Centers for Disease Control and Prevention on vaccines will not convene for its February ...

A meeting of vaccine advisers set for late February has been postponed, a federal official confirmed on Thursday, raising new ...

GSK (GSK) announced that the China National Medical Products Administration, CNMPA, has accepted for review the new drug application for the ...